Management of recurrent disease after radical prostatectomy-Reference-Cited by-同舟云学术

Management of recurrent disease after radical prostatectomy

Published:2004-07-27 Issue:3 Volume:7 Page:211-216
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Bott S R J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/4500732.pdf

Reference61 articles.

1. Han M et al. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol 2001; 166: 416–419.

2. Bott SRJ et al. Radical Prostatectomy: pathology findings compared with other major series and over time. Prostate 2002. Liverpool, UK, 2002; Abstract.

3. Pound CR et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591–1597.

4. Fowler Jr FJ et al. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988–1990 (updated June 1993). Urology 1993; 42: 622–629.

5. Lu-Yao GL et al. Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. J Natl Cancer Inst 1996; 88: 166–173.

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delayed Imaging Improves Lesion Detectability in [^99mTc]Tc-PSMA-I&S SPECT/CT in Recurrent Prostate Cancer;Journal of Nuclear Medicine;2023-05-25

2. Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy;Frontiers in Oncology;2022-10-17

3. EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort;Frontiers in Pharmacology;2022-09-19

4. Detection efficacy of PET/CT with 18F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study;Annals of Nuclear Medicine;2022-01-22

5. 68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors;Translational Oncology;2022-01